Aboriginal Australians aged 20-59 with atrial fibrillation had significantly higher hazards of stroke (aHR 1.67; 95% CI 1.22-2.28) and cardiovascular mortality than non-Aboriginal patients.
Cohort (n=55,482)
Does Aboriginal Australian status increase the risk of stroke and cardiovascular mortality in patients hospitalized with atrial fibrillation?
Aboriginal Australians hospitalized with atrial fibrillation, particularly those under 60, have a markedly higher risk of stroke and cardiovascular mortality compared to non-Aboriginal patients.
Effect estimate: aHR 1.67 (95% CI 1.22-2.28)
Objectives To assess the risks of stroke and cardiovascular mortality for Aboriginal and non-Aboriginal Australians with atrial fibrillation. Design Retrospective data linkage cohort study. Setting, participants All people aged 20–84 years hospitalised with atrial fibrillation in Western Australia during 2000–2012. Main outcome measures Stroke incidence rates and mortality after hospitalisation for atrial fibrillation, and 10-year risks of stroke and of cardiovascular and all-cause mortality. Results Among 55 482 index admissions with atrial fibrillation, 7.7% of 20–59-year-old patients and 1.3% of 60–84-year-old patients were Aboriginal Australians. A larger proportion of Aboriginal patients aged 20–59 years had CHA2DS2-VASc scores of 2 or more (59.8% v 21.8%). In 20–59-year-old Aboriginal patients, the incidence during follow-up (maximum, 10 years; median, 7.1 years) of stroke (incidence rate ratio IRR, 3.2; 95% CI, 2.5–4.1) and fatal stroke (IRR, 5.7; 95% CI, 3.9–8.9) were markedly higher than for non-Aboriginal patients. Stroke incidence was higher for 60–84-year-old patients, but the difference between Aboriginal and non-Aboriginal patients was smaller (IRR, 1.6; 95% CI, 1.3–2.0). Cardiovascular mortality during follow-up was also higher for 20–59-year-old Aboriginal patients (IRR, 4.4; 95% CI, 4.3–5.9). The hazards of stroke (adjusted HR aHR, 1.67; 95% CI, 1.22–2.28) and cardiovascular mortality (aHR, 1.47; 95% CI, 1.18–1.83) in younger Aboriginal patients remained significantly higher after multivariable adjustment; age/sex, principal diagnosis of atrial fibrillation, and CHA2DS2-VASc score were the most influential factors. Conclusion Stroke risk and cardiovascular mortality are markedly higher for Aboriginal than non-Aboriginal patients with atrial fibrillation, particularly for patients under 60. Strategies for providing evidence-based therapies and cardiovascular prevention to Aboriginal people with atrial fibrillation must be improved.
Nedkoff et al. (Thu,) conducted a cohort in atrial fibrillation (n=55,482). Aboriginal Australian ethnicity vs. non-Aboriginal Australian ethnicity was evaluated on stroke incidence in 20-59-year-old patients (aHR 1.67, 95% CI 1.22-2.28). Aboriginal Australians aged 20-59 with atrial fibrillation had significantly higher hazards of stroke (aHR 1.67; 95% CI 1.22-2.28) and cardiovascular mortality than non-Aboriginal patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: